Skellerup Holdings Limited — Director's Dealing 2017

Sep 29, 2017

==> picture [83 x 22] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

		e)
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financial products(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:		N/A
For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		One
Date of transaction:		18 September 2017
Nature of transaction:		On-marketpurchase
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration:		$8,400.00
Number of financialproducts to which the transaction related:		5,000 OrdinaryShares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod:		N/A
Date of theprior written clearance (if any):		N/A
Summary of other relevant interests after acquisition or disposal: Class ofquoted financialproducts:
Class ofquoted financialproducts:		OrdinaryShares(NZX Code: SKL)

Nature of relevant interest:		(1) Registered holder as trustee of the DM2 Investment Trust, in which David Mair has a beneficial interest ~~(2) David Mair holds 20% or more of the voting securities of Forte Funds Management~~
		Limited as trustee, and therefore has the same relevant interests as Forte Funds
		Management Limited. Forte Funds Management Limited has the power to control the
		acquisition or dispostion of, and the right to vote attached to 2,799,402 shares in
		Skellerup Holdings Limited. David Mair does not have a beneficial interest in these
		shares.
_For that relevant interest,- _
Number held in class:		(1)3,527,506
		(2)2,799,402
Current registered holder(s):		(1)David W Mair & John G Phipps
		(2)Public Trust Forte Nominees Limited
For a derivative relevant interest,-
Type of derivative:		N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payable under
the derivative or the value of the derivative is affected by the value of the underlying		N/A
financialproducts:
For that derivative relevant interest,-
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:		N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		29 September 2017
Name and title of authorisedperson:		Graham Leaming, CFO

==> picture [499 x 121] intentionally omitted <==